Try our Advanced Search for more refined results
Synthego Corporation Inter Partes Review
Case Number:
Case Type:
IPR
Status:
Final Written Decision - Appealed
Petitioner:
Synthego Corporation
Patent Owner:
Tech Center:
-
Filed: January 05, 2022 00:00
Coverage
-
May 17, 2023
Synthego Gets PTAB To Ax 2 Agilent CRISPR Patents
The Patent Trial and Appeal Board found Wednesday that two Agilent Technologies Inc. patents on the gene-editing tool CRISPR were invalid, the latest dustup in a legal fight brought by Synthego Corp. over the breakthrough technology.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the PTAB case documentsAlready a subscriber? Click here to login
-
May 17, 2023